| Line Item | 2025-09-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $699.9M | +14.0% | -3.7% |
| R&D Expense | $41.5M | -9.2% | -25.8% |
| SG&A Expense | $186.9M | +5.0% | +0.3% |
| Operating Income | -$704.8M | -290.0% | -4798.7% |
| Pre-tax Income | -$756.9M | -229.7% | -2528.1% |
| Income Tax | -$23.9M | -192.6% | -168.5% |
| Net Income | -$733.0M |
| Line Item | 2025-09-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $98.1M | -35.3% | -31.7% |
| Accounts Receivable | $386.5M | +40.5% | +31.1% |
| Inventory | $613.8M | +6.1% | +6.4% |
| Current Assets | $1.37B | +6.6% | -3.2% |
| Total Assets | $5.68B | -11.0% | -16.6% |
| Current Liabilities |
| Line Item | 2025-09-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$26.7M | — | — |
| Capital Expenditures | $142.9M | — | — |
| Investing Cash Flow | -$143.1M | — | — |
| Financing Cash Flow | $166.9M | — | — |
| Free Cash Flow | -$169.6M | — | — |
| -187.0% |
| -3583.4% |
| EPS (Basic) | -$10.78 | -185.9% | -3493.3% |
| EPS (Diluted) | -$10.78 | -185.9% | -3493.3% |
| $767.9M |
| -32.8% |
| -25.3% |
| Long-term Debt | $2.50B | +20.5% | +14.7% |
| Total Liabilities | $3.64B | +1.5% | +0.7% |
| Stockholders' Equity | $2.04B | -27.1% | -36.1% |